Pfizer Inc

See the following -

DIA 2014 50th Annual Meeting To Highlight TransCelerate BioPharma Collaboration

Press Release | DIA, TransCelerate | May 6, 2014

Industry leaders in R&D will examine accomplishments, progress and 2014 line extensions. Susan Cantrell, senior vice president and managing director for DIA Americas, will chair the panel discussion “Collaboration in R&D: What’s New for TransCelerate BioPharma?” during DIA’s 2014 50th Annual Meeting at the San Diego Convention Center from June 15 to 19...

Read More »

Pfizer Unveils ATLAS®, An Interactive, User-Friendly Website That Provides Global Antibiotic Resistance Surveillance Data Across 60 Countries

Press Release | Pfizer Inc. | April 21, 2017

Pfizer Inc. today announced the launch of the company’s Antimicrobial Testing Leadership and Surveillance (ATLAS) website, which is designed to provide physicians and the global health community with easy access to critical data on the efficacy of various antibiotic treatments and emerging resistance patterns across more than 60 countries. Understanding evolving bacterial resistance patterns is a key element in managing the rise of antimicrobial resistance. To that end, ATLAS can not only help physicians select the most appropriate treatment choices for their patients, but also enable global health authorities to develop data-driven antimicrobial resistance mitigation strategies...